Stop Smoking With Hypnotherapy Study A Proposal. Bupropion studies 615 smokers – randomised to drug 100mg, 150mg, 300mg or placebo for 7 weeks Try to.

Slides:



Advertisements
Similar presentations
NC STEP/Mission Hospitals School Cessation and Treatment Guide.
Advertisements

Nicotine Gum Nicotine absorbed mucosal membranes 2mg and 4mg strength
How to practice EBM: Finding the Evidence Owen Coxall & Nia Wyn Roberts Bodleian Health Care Libraries.
A Clinical Flow-Chart for the “Treatment-Resistant Smoker”
Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Pre-cessation nicotine treatment Jean-François ETTER Dr polit. sci, privat docent Institute de Médicine Sociale et Préventive Faculté de Médecine, Université.
Experiment Subjecting the sample to a controlled treatment. Explanatory variables explain or cause a change in the response variable. These determine the.
Risk Assessment and Reduction Counselling Session 5.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Presented by: Asfiya Afsar Nadia Barak Catriona Hagley SMOKING CESSATION.
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
Philip Tønnesen,2005 Smoking cessation Philip Tønnesen, M.D, Dr.med.sci.
Stop Smoking With Hypnotherapy Training Day Ursula James Mark Feldman.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Smoking cessation in New Zealand
Smoking Cessation in Smokers Motivated to Quit Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Robert Anthenelli.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
Module 2 - Assessment, Diagnosis, and Pharmacotherapy: Integrating Tobacco Use Interventions into Chemical Dependence Services.
A Randomised Double-Blind Study of Weight Reducing Effect and Safety of Rimonabant in Obese Patients with or without Comorbidities A Randomised Double-Blind.
What we need to know about smoking & tobacco addiction.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Smoking Cessation: the pharmacotherapeutic and non-pharmacotherapeutic approaches to addictive behavior Andrea C. McKean February 22, 2007.
Psychopharmacology (the study of drug effects on mind and behavior)
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Nortriptyline, St John’s wort, and glucose, do they help? Paul Aveyard Senior Lecturer Department of Primary Care & General Practice University of Birmingham.
The Alabama Tobacco Quitline and July 22, 2010.
ABSTINENCE AND RELAPSE AMONG SMOKERS WHO USE VARENICLINE FOR QUITTING—A POOLED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Shade Agboola, Ann McNeill, Tim.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Fighting Obesity and Inactivity: Role of Parks and Community Siripoom McKay, MD.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
Effects of a combination of varenicline and nicotine patch on post-quitting urges to smoke Katie Myers Smith BSc MSc CPsychol Research Fellow Wolfson Institute.
The University of Wisconsin Medical School The Center for Tobacco Research and Intervention Treating Tobacco Addiction in a Subject concerned about Weight.
Nico-hosp-intro 1.1 Smoke-free hospital European Training guide From: Nicomède DGS France Bupropion (Zyban®) NHC(CH 3 ) 3 COCHCH 3 HCl Cl Non-nicotine.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
Attempting to increase the use of smoking cessation medications Brendon Baker Ministry of Health.
Baseline characteristics. Patient flow Completed Completed Perindopril Placebo Randomised Not randomised Registered.
Better Health. No Hassles. Nicotine Dependence Addiction to tobacco products. Nicotine produces physical and mood-altering effects that are temporarily.
Asthma management across ages Asthma in pregnancy Rule of one thirds (BTS/SIGN 2004)  1/3 improvement  1/3 worsening  1/3 stay the same.
Varenicline: A Tale of Three Molecules Douglas E. Jorenby, Ph.D. Associate Professor of Medicine Univ. of WI School of Medicine and Public Health The Center.
Types of help Available NHS Stop Smoking Services Nicotine Replacement Therapy (NRT) Other Pharmacological Treatments (non nicotine) Alternative Therapies.
1 Access to and use of aids to smoking cessation in the UK Robert West University College London Austin, Texas February 2007.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Wellbutrin 150 Mg High Cheap Wellbutrin Online wellbutrin sharp pain head wellbutrin causing aggression watson labs bupropion xl wellbutrin and quitting.
ISO 9001 Registered ASH KAN Assessment of smoking history, knowledge & attitudes of nurses in New Zealand Hayden McRobbie, Clinical Trials Research Unit.
Pharmacotherapy for Smoking Cessation
Unit 14 – Exercise, Health and Lifestyle
Smoking Cessation Medication
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
Dr. Sumaya Aboulhosn ALMA
Smoking and smoking cessation in the real world
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts
Changes to the UK licence for NRT: rationale
Behavioural and pharmacological approaches to treating smokers
BTEC National Diploma in Sport
QuitlineNC Funding.
Tobacco Cessation Guidelines for COPD
ABCs of Behavioral Support
EVITA Trial design: Smokers admitted with an acute coronary syndrome were randomized to varenicline 1 mg twice daily (n = 151) vs. placebo (n = 151). Study.
Hilary Millar, Val Reilly, Liz McGovern
Margaret B. Nolan, MD, David O. Warner, MD  Mayo Clinic Proceedings 
Presentation transcript:

Stop Smoking With Hypnotherapy Study A Proposal

Bupropion studies 615 smokers – randomised to drug 100mg, 150mg, 300mg or placebo for 7 weeks Try to stop at 1 week For 300 mg - at 7 weeks[course end] –10.5% stop with placebo –24.4% stop with drug At one year point prevalence [ no smoking for last week] –12.4% placebo –23.1% drug

Bupropion studies 893 smokers one of 4 treatments for 9 weeks – 12 month point prevalence –Placebo oral + placebo patch  15.6% –Bupropion 300mg + placebo patch  30.3% –Nicotine patch + oral placebo  16.4% –Bupropion 300mg + nicotine patch  35.5%

Bupropion studies Continuous absence rates = –Bupropion alone  18.4% –Bupropion +patch  22.5% Cost –£86 + counselling – 5 sessions

Bupropion studies Problems with Bupropion –11% dry mouth –42% insomnia –6% hypertension { if given with patch} –1: fitting

Bupropion studies Contraindications –Epilepsy –Pregnancy –History of fits –History of head injury –Diabetes on drugs or insulin –Patients on TheophyllineSystemic steroids Antipsychotics Antidepressants

Hypnotherapy Studies Hypnotherapy –Safe –Specific Difficult to generalise Few published single session studies

Hypnotherapy Studies 226 Smokers [ Spiegel Frishholz Spiegel] –Single session treatment –2 year follow up 53% stop at one week 23% stop at two years

Hypnotherapy Studies 40 patients [Berkowitz Townsend Kohberger] –Single session 25% stop at 6/12

Hypnotherapy Studies LCCH method Single sessions Cost £ 150 approx Easily learned No side effects Does it work ??

Hypnotherapy Studies LCCH study –Single hypnotherapist –LCCH method One hour session only –Follow up one month to one year –Postal Questionnaire

LCCH Study Results 59 questionnaires sent { follow up 1/12 to 1 yr } –35 Returned 59.3% Of those returned –30 stopped 85% –1 cut down 2.8% –4 continued unchanged 11..4% At one month –23 stay stopped 65.7%

LCCH Study Results Results beyond this unsatisfactory due to lack of follow up BUT no known restarters after 6 months –Restarters 3 at less than one month 4 at 1-3/12 2 at 4-6/12 –We have a definite 12 stopped at one year { 34% } but as data is incomplete Could presume 21 stopped at one year which would be 60% stop at one year

LCCH Study Results

Hypnotherapy Proposal Randomised study - Possible Studies In conjunction with Community Stop Smoking Clinics Single session LCCH method hypnotherapy Vs Bupropion + counselling Possible arms –Single session hypnotherapy –Single session hypnotherapy + NRT –Single session hypnotherapy + Bupropion –Bupropion + counselling